Evaluation of Clotting and Bleeding Risks Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia.

Saved in:
Bibliographic Details
Title: Evaluation of Clotting and Bleeding Risks Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia.
Authors: Cendagorta, Alyssa1,2, Lattuca, Frank1,2, Moore, Jeremiah E.1,2, O'Dwyer, Kristen3, Baran, Andrea4, Acquisto, Nicole M.5, Treptow, Carissa6
Source: Journal of Hematology Oncology Pharmacy. Feb2026, Vol. 16 Issue 1, p13-21. 9p.
Database: Academic Search Ultimate
Description
ISSN:21641153